Objective: To analyze, in morbid obese patients, the expression of several human genes regulating cortisol metabolism, such as glucocorticoid receptor (GR), 11b-hydroxysteroid dehydrogenase type 1 (11bHSD1), 11b-hydroxysteroid dehydrogenase type 2 (11bHSD2), stearoyl-acute regulatory protein (StAR), 5a-reductase type I (5a-R) and peroxisome proliferator-activated receptor-g (PPARg) in two different adipose depots. A second objective was to characterize the circadian rhythmicity of these genes in both adipose tissue (AT) regions. Design: Visceral and subcutaneous abdominal AT biopsies were obtained from obese patients (body mass index X40 kg m À2 ). To carry out rhythmic expression analysis, AT explants were cultured for 24 h and gene expression at times (T ) 0, 6, 12 and 18 h, was performed with quantitative real-time PCR. Result: GR, 11bHSD1 and PPARg genes were highly expressed in both subcutaneous and visceral depots. StAR and 5a-R genes were detected at lower levels. The expression of 11bHSD2 was quantified in both AT depots with a higher expression in the visceral depot (P ¼ 0.032). Both sexes had similar gene expression levels, except for 5a-R (P ¼ 0.002). The genes studied showed circadian rhythmicity being more robust in visceral than in subcutaneous AT. Genes ranged in anti-phase between both depots (P ¼ 0.002). This rhythmicity was maintained in an AT culture. Conclusion: We have shown for the first time circadian rhythmicity in glucocorticoid-related gene expression in human AT ex vivo. These results may have potential therapeutic implications with respect to the pathogenesis and treatment of diseases, such as obesity, type 2 diabetes and cardiovascular diseases.
Introduction
Although the prevalence of hypertension, coronary artery disease and diabetes mellitus rises with increasing body mass index (BMI), it is central obesity or visceral fat accumulation that carries, by far the worst prognosis in terms of cardiovascular risk profile and sudden death. 1 Cushing's syndrome, caused by high cortisol production, is associated with similar metabolic abnormalities, with an increase in the size of intra-abdominal fat stores compared with subcutaneous fat. Visceral obesity and Cushing's syndrome share similar metabolic alterations, such as insulin resistance and increased cardiovascular risk. 2 In both diseases, there is evidence of increased cortisol production rate, but in contrast to Cushing's patients, in obesity, the increased cortisol synthesis is not associated with consistent elevation of plasma cortisol levels. 3 In fact, circulating cortisol levels may even be lower in obese patients than in lean patients, and intra-adipose cortisol metabolism has been hypothesized as the reason for this low cortisol plasma concentration. 4 On the other hand, subjects with visceral obesity show subtle perturbations of the cortisol diurnal rhythm, with a significant decrease in cortisol variability, suggesting that a disturbed hypothalamic-pituitary-adrenal (HPA) axis response may lead to an android pattern of body. 5 It has been shown that biological rhythms have an impact on most aspects of physiology. 6 Regarding cortisol metabolism, some genes could be influencing the fluctuation of this hormone in plasma through the day, especially in morbid obese subjects characterized by a high adipose mass content. 7 Surprisingly, the expression pattern of these genes has not been characterized to date. At a tissue-specific level, the access of cortisol into adipose depots depends on numerous factors. The ability of cortisol to bind to the corticosteroid receptorsF mineralocorticoid and glucocorticoidFis controlled by two isoenzymes of 11b-hydroxysteroid dehydrogenase (11bHSD1 and 11bHSD2). Other enzymes can increase cortisol availability, such as stearoyl-acute regulatory protein or StAR, a key factor in steroidogenesis mediating the transfer of cholesterol from the outer to the inner mitochondrial membrane. By contrast, cortisol can be inactivated by other enzymes; for example, steroid 5a-reductase type I (5a-R), an A-ring reductase that enhances cortisol clearance in peripheral tissues, mainly the liver. [8] [9] [10] In addition, the action of these genes can be regulated upstream by other factors that are crucial for the metabolism of adipose tissue (AT); for example, 11bHSD1 activity is regulated by peroxisome proliferator-activated receptor-g (PPARg).
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Depot-specific expression of cortisol-related genes is difficult to test in human studies. Measurements of omental fat are usually limited by its inaccessibility. In fact, there are a few studies comparing 11bHSD1 expression level between subcutaneous and visceral depots in obese [12] [13] [14] and nonobese 15 humans; however, only one study has found 5a-R or StAR expression in AT, but in non-obese subjects, 15 and none has apparently tested 11bHSD2, although it has been described in rodents. 16 To our knowledge, this is the first attempt to investigate the circadian rhythmicity for cortisol-related genes in human AT. The objectives of this study were, first, to analyze, in a morbid obese population, the expression of several human genes regulating cortisol metabolism in two different adipose depots, and, second, to characterize the 24-h circadian rhythm of those genes in both AT regions.
Subjects and methods

Subjects
Visceral and subcutaneous abdominal AT biopsies were obtained from a total of 18 patients, 8 men (age 43±13 years and BMI 47.21 ± 5.24 kg/m 2 ) and 10 women (age 46 ± 10 years and BMI 52.26 ± 25.29 kg/m 2 ), from the General Surgery Service of 'Virgen de la Arrixaca' University Hospital, undergoing laparoscopic gastric bypass surgery because of obesity. Patients had normal kidney and hepatic functions at the time of enrollment. The average time of sleep onset was 0130 hours (range 2330-0330 hours) and that for awakening was 0800 hours (range 0645-1130 hours). The day before surgery, all patients were synchronized having lunch at 1430 and having dinner at 2100 hours.
After an overnight fast, AT biopsies were taken as paired samples from the two AT depots (visceral and subcutaneous) at the beginning of the surgical procedure (estimated time of biopsies sampling from 1000 to 1400 hours). From the women group, a higher quantity of AT was obtained, to carry out rhythmic expression analysis. We selected this group because we had earlier shown the interaction between circadian rhythmicity of plasma cortisol and body fat distribution in women, and we wanted to confirm these results in AT explants culture.
The clinical characteristics of both men and women are shown in Table 1 . The protocols were approved by the ethics committee of the 'Virgen de la Arrixaca' University Hospital, and all the subjects signed a written informed consent before the biopsies were obtained.
Clinical characteristics
Weight was determined in subjects wearing light clothes and barefooted, using a digital electronic weighing scale. Height was determined using a Harpenden digital stadiometer (range 0.70 -2.05 m), with the subject upright and the head in the Frankfurt plane. From these data, the BMI was calculated.
Total body fat (%) was measured by bioimpedance with TANITA Model TBF-300 (Tanita Corporation of America, Arlington Heights, IL, USA). 17 Body fat distribution was assessed using the waist circumference midway between the lower rib margin and the iliac crest and hip at the level of the widest circumference over the great trocanters. The waist-tohip ratio was calculated from both measurements. Anthropometric measurements were carried out thrice by the same anthropometrist.
Adipose tissue culture After laparoscopy in each patient, paired AT samples (4-5 g) were obtained from both fat depots (subcutaneous and Cortisol-related genes circadian expression JJ Hernandez-Morante et al visceral) approximately around 1000 -1400 hours, and then were immediately carried to the laboratory to perform the primary adipose culture. AT was carefully dissected from the skin and vessels and cut into small pieces (average weight of 10 mg), and all subsequent procedures were carried out under laminar airflow and sterile conditions. All cultures were carried out in duplicate. The explants were then placed in 100-mm-diameter dishes at 37 1C for 24 h in a humidified atmosphere containing 7% CO 2 . AT (800 -1000 mg) was placed in 5 ml of Dulbecco's modified Eagle's medium supplemented with 10% fetal bovine serum. 18 The next day, the adipose explants were collected to perform gene expression analysis at times (T ) 0, 6, 12 and 18 h, in which T0 was arbitrarily defined as 0800 hours because this was the usual waking time for patients. The time of sample collection is displayed in the chronogram shown in Figure 1 . All cultures were carried out in duplicate.
Analysis of gene expression RNA extraction from isolated adipocytes. Total RNA was extracted from isolated adipocytes using RNeasy Kit (Qiagen, Courtaboeuf, France) according to the manufacturer's instructions, except that the fat cake was removed by centrifugation before loading the purifying columns. RNA was quantified by measuring absorbance at 260 and 280 nm. The integrity of the RNA was checked by visual inspection of the two ribosomal RNAs (rRNAs), 18S and 28S, on 1% agarose gel.
Real-time PCR measurement. Reverse transcription was carried out using random hexamers as primers and Thermoscript reverse transcriptase (Invitrogen, Cergy-Pontoise, France) with 1 mg total RNA for each sample. Quantitative real-time PCR was carried out using an ABI PRISM 7900HT Sequence Detection System (Applied Biosystems, Foster City, CA, USA) as described by the manufacturer. PCR Master MIX (PerkinElmer, Norwalk, CT, USA) containing Hot Start Taq DNA polymerase was used. TaqMan probes for human 11bHSD1, 11bHSD2, glucocorticoid receptor (GR), 5a-R, StAR and PPARg were used. We used glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and 18S rRNA as internal control, which were also supplied by Applied Biosystems (Assay-by-Design). All samples were determined as duplicates, and for a negative control the same setup was used except for the addition of reverse transcriptase. No PCR product was detected under these latter conditions. In brief, mRNA from each gene was amplified in separated wells at 95 1C for 10 min and, thereafter, in repeating cycles for annealing and extension steps at 95 1C for 30 s and 60 1C for 60 s. During the extension step, increase in fluorescence was measured in real time.
Data were obtained as C t values according to the manufacturer's guidelines, and were used to determine the DC t values (DC t ¼ C t of the target geneÀC t of the housekeeping gene (18S)) of each sample. Fold changes of gene expression were calculated by the 2 ÀDDCt method. 19 We selected 18S because this gene showed a lower variance along time compared with the GAPDH gene. In addition, we carried out a one-way (Zeitgeber time, ZT) analysis of variance (ANOVA) for 18S and observed no significant difference in any of the adipose depots studied (P40.05). In addition, there was no significant difference in 18S C t between subcutaneous (mean C t ¼ 23.3 ± 3.3) and visceral depots (mean C t ¼ 23.2 ± 3.3). In conclusion, we selected 18S as the better housekeeping gene for this experiment.
Statistical analysis
Clinical and anthropometric data are presented as means ± s.d. The results for gene expression, expressed in arbitrary units, are presented as means±s.e.m. Data concerning gene expression in the subcutaneous and visceral depots were analyzed as DC t to exclude potential bias because of averaging data that had been transformed through the equation 2 ÀDDCt . 20 We used Student's t-test to analyze possible differences between sexes. Student's paired t-test was used for comparing data from the samples derived from the two adipose depots in each individual subject. Comparisons among ZT gene expression levels into each fat depot were analyzed by means of the repeated measures ANOVA test, with a post hoc test of Bonferroni correction. The single cosinor method was used to analyze for circadian rhythm, individually and as a group. This inferential method involves fitting a curve of predefined periods by the method of least squares. The rhythm characteristics and their dispersion s.e. estimated by this method include the mesor (middle value of the fitted cosine representing a rhythmadjusted mean), the amplitude (half the difference between the minimum and maximum of the fitted cosine function) and the high point or acrophase (time of peak value in the fitted cosine function expressed as the lag in hours and Cortisol-related genes circadian expression JJ Hernandez-Morante et al minutes from midnight). Differences in rhythmicity among the genes studied and between AT depots were analyzed comparing the amplitude and the percentage of variance by ANOVA and Students' paired t-test. The significance level of the rhythms was determined by 60% rejection of the zero amplitude hypotheses. All statistical analyses were carried out using SPSS for windows (release 15.0; SPSS Inc., Chicago, IL, USA). The level of significance for all statistical tests and hypotheses was set at Po0.05.
Results
Clinical characteristics of the population Table 1 contains general characteristics of the population studied. BMI was higher than 40 kg/m 2 in these patients, indicating morbid obesity. According to the International Diabetes Federation, these subjects met the criteria to be defined as patients with the metabolic syndrome.
Cortisol metabolism-related gene expression in human biopsies As shown in Figure 2 , GR, 11bHSD1 and PPARg were highly expressed in both subcutaneous and visceral depots in the population studied. StAR and 5a-R mRNAs were also detected, albeit at lower levels. The expression of 11bHSD2 was also quantified in both AT depots (Figures 2a and b) . Both sexes showed similar gene expression levels except for 5a-R, which was higher among men ( Figure 3) . When comparing the gene expression levels between subcutaneous and visceral areas in the studied population, 11bHSD2 expression was significantly higher in the visceral location (Figure 2c ). Among men, 5a-R expression was also higher in visceral than in subcutaneous AT (P ¼ 0.034).
Circadian gene expressions in women adipose tissue
Once the basal expression of these cortisol-related genes had been studied, we focused on their circadian expression pattern in cultured AT explants. Parameters imputed from each subject, obtained by cosinor analysis, defining the circadian rhythms as mesor, amplitude, acrophase and percentage of variance for both subcutaneous and visceral depots are shown in Table 2 . According to these results, we have observed circadian expression patterns for all the genes investigated (represented in bold faces). Moreover, statistical difference among the ZTs gene expression was found in visceral AT for GR (P ¼ 0.04), 11bHSD1 (P ¼ 0.011), PPARg (P ¼ 0.018) and 5a-R (P ¼ 0.035). Figure 4 illustrates the comparative mean circadian rhythms of the studied genes for the total population. Both AT locations showed marked circadian rhythmicity in all the genes studied, being more robust in the visceral than in the subcutaneous depot. Most of the genes ranged in anti-phase in visceral and in subcutaneous AT (P ¼ 0.002). Among the genes studied, 
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PPARg was the gene with the highest rhythmic expression in both AT areas, followed by 11bHSD1.
Phase map of the genes studied
In subcutaneous AT, all the genes that were studied showed the acrophase, or the time at which the peak of the rhythm occurs, in the morning (at 0800 hours), except for 11bHSD2, which presented the acrophase earlier. However, visceral AT behaves in a different way, with the acrophase at night (T ¼ 15, coinciding with 2300 hours).
Discussion
The first aim of this study was to evaluate the expression levels of several cortisol metabolism-related genes in human AT to explore the ability of fat tissue to regulate cortisol Abbreviations: 5a-R, 5a-reductase type I; 11bHSD1, 11b-hydroxysteroid dehydrogenase type 1; 11bHSD2, 11b-hydroxysteroid dehydrogenase type 2; GR, glucocorticoid receptor; PPARg, peroxisome-proliferator activated receptor-g; StAR, stearoyl-acute regulatory protein. Circadian expression patterns for all the genes investigated are represented in bold face.
Cortisol-related genes circadian expression JJ Hernandez-Morante et al physiology. In this regard, our data suggest that intra-depot cortisol action can be modified by a cluster of genes that are expressed in human AT, derived from both subcutaneous and visceral areas. From all the genes studied, GR, 11bHSD1 and PPARg were the most expressed in both fat depots, which could indicate their potential relevance in the regulation of glucocorticoid metabolism in AT.
Human 11bHSD1, the enzyme allowing the regeneration of cortisol, has been described as a gene highly expressed in AT. 21 In this study, we showed that it was highly expressed in both AT locations, although we have not found any significant difference between visceral and subcutaneous biopsies, as reported earlier by Tomlinson et al.
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Contrary to 11bHSD1, 11bHSD2 inactivates cortisol to cortisone. Although in obese rats 11bHSD2 is upregulated in fat tissue and strongly correlated with adiposity, 16, 23 its expression in human AT has been a topic of intense debate. 24 In 2004, Engeli et al. 25 detected 11bHSD2 expression in human subcutaneous AT biopsies using real-time PCR, whereas earlier reports from Yang et al.
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and Bujalska et al. 2 failed to find any expression of this gene, probably as a consequence of the use of lesssensitive techniques such as northern blot or conventional PCR.
In this study, we have quantified 11bHSD2 expression in intra-and extra-abdominal fat depots. The higher expression of this gene in visceral AT observed in this work could influence site-specific cortisol metabolism and its relation with the metabolic syndrome.
There are many potential confounders that may influence cortisol metabolism, apart from 11bHSD isoenzymes. Cortisol-related genes circadian expression JJ Hernandez-Morante et al
Especially relevant are the cortisol activating enzyme, StAR, and the deactivating enzyme, 5a-R. 27, 28 In this study, both enzymes were expressed in AT, although at very low levels. 5a-R activity 29 and mRNA have been detected earlier in rodent omental fat, where they were overexpressed when the rodents were fed a high-fat diet. 30 Increased glucocorticoid conversion by the reductases (a and b) may enhance glucocorticoid clearance and a feedback regulation of the HPA axis. 10 Our data show that 5a-R has the lowest expression level of all the array of genes studied, with men showing a higher expression than do women. However, these differences could be a consequence of the A-ring reductase activity, also important for converting testosterone to dihydrotestosterone. 27 Hence, a higher expression in men could be, at least partially, a consequence of an enhanced testosterone metabolism. As GR activation by cortisol, usually associated with insulin resistance, causes fat accumulation, notably in omental AT, 31 the differential expression of this enzyme could be important in the gender differences in obesity, including related alterations and fat distribution patterns.
Regarding StAR expression, we have not found differences between sexes or between fat depots. This result does not fit with the recently reported results by other groups in nonobese women 15 or rats, 28 in which StAR expression was higher in visceral fat. The second objective of this study was to characterize the circadian rhythm of some glucocorticoid metabolism-regulating genes in both AT regions derived from a morbid obese population. In this regard, the main observation was that all the studied genes showed significant daily fluctuation. Further studies should be performed in lean subjects to probe if this circadian rhythmicity is even higher.
An important consideration for this work is that rhythmicity persists at least for 24 h even outside the organism, as other authors have recently reported the preservation of oscillations in the expression of some clock genes in ex vivo tissues, such as aortic smooth muscle 32 heart, liver, kidney and fibroblast cells. 33, 34 However, this has not been reported in human AT until now. This persistence of in vitro gene expression oscillations strongly suggests its direct regulation by endogenous factors, which modulate the circadian expression of these genes in adipose explants in an autocrine manner. For this purpose, there are many candidates. In fact, it has been shown that ligands of the GR, ligands of RARa and RXRa transcription factors, calcium ionophores and other chemical drugs can trigger circadian gene expression in cell cultures. 35 Fontaine et al. 36 have recently reported that PPARg can directly regulate the transcription of different clock genes that govern the 24-h circadian rhythms of the body. In our fat explants, the expression of this gene has shown a marked rhythmicity, oscillating in phase with most of the other genes, which could be related to the intra-AT circadian metabolism. We have shown that cortisol and the enzymes regulating its metabolism are circadian hormones, not only in the global physiological situation of the patient, as widely shown in plasma and salivary determinations, with peaks in the morning and low values in the evening, 5 but also in a specific tissue as relevant for obesity and cortisol-related pathologies as AT. The higher circadian rhythmicity shown in intra-abdominal than in subcutaneous fat could be relevant in the depot-specific glucocorticoid regulation. In this sense, it has been suggested that a decrease in tissuespecific cortisol production might improve insulin sensitivity and prevent diabetes. 37 and The inactivation of 11bHSD1 as a novel treatment for the metabolic syndrome has been recently proposed. 38 In addition, we have found that both AT depots showed an anti-phase rhythmicity, suggesting that the internal circadian regulation could act in a different manner in both ATs or that the response to these circadian markers could differ between both regions. It should be noted that this study is an ex vivo study. Moreover, because the mass of AT is obtained during surgery process, the amount taken for analysis was too small to perform four different adipose cultures in duplicate. Hence, this study focused only on gene expression. Other studies performed in cortisol concentrations or enzyme activity will be needed to confirm or refute this. Another caveat of this study is the small sample size; however, considering the overall ethical aspects, the number of patients seems to be enough to assess the gene expression analysis.
In conclusion, we have shown circadian rhythmicity in glucocorticoid-related gene expression in AT. Moreover, this rhythmicity is maintained even in AT-cultured explants. The robust expression variability in genes from visceral AT could be relevant for a deeper knowledge of the importance of this depot in the development of the metabolic syndrome. From all the genes analyzed, GR, 11bHSD1 and PPARg are the most expressed in both depots, but an important consideration for the knowledgeability of glucocorticoid metabolism in this tissue could be the differential expression of 11bHSD2 in subcutaneous and visceral AT. 5a-R shows special relevance in differentiating genders.
The presence of circadian oscillations in AT has significant metabolic alterations, and their characterization may have potential therapeutic implications with respect to the pathogenesis and treatment of diseases, such as obesity, type 2 diabetes and the metabolic syndrome.
